COVID-19 and Cardiovascular Comorbidities

25Citations
Citations of this article
107Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The emergence of a new coronavirus - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - has resulted in a global pandemic. The associated coronavirus disease 2019 (COVID-19) has resulted in a high number of death worldwide. Observational studies and case reports have provided insights that older age and the presence of chronic diseases is frequently associated with a higher COVID-19 severity. These individuals also seem to have a higher risk of mortality due to COVID-19. In this review we provide insights into the impact chronic diseases associated with the cardiovascular system, such as obesity, diabetes mellitus, hypertension and cardiovascular disease might have on SARS-CoV-2 infection and COVID-19. Additionally we review recommendations and guidance's of international scientific associations and discuss which key learnings might be of importance for the future.

Cite

CITATION STYLE

APA

Müller-Wieland, D., Marx, N., Dreher, M., Fritzen, K., & Schnell, O. (2022, March 1). COVID-19 and Cardiovascular Comorbidities. Experimental and Clinical Endocrinology and Diabetes. Georg Thieme Verlag. https://doi.org/10.1055/a-1269-1405

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free